Lukas Biomedical Inc.
6814
Rank in Stocks
#26071
Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc.... Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc. primarily develops immune cell medical technologies. These innovations are utilized for regenerative medicine and as complementary treatments for cancer. The company's operations are segmented into four distinct areas: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. Furthermore, it diversifies its business by wholesaling and retailing cosmetics, alongside providing housing equipment rental services.
Share Price
$0.53347803
Last synced: 2026-11-10
Market Cap
$22.34M
Change (1 day)
-0.57%
Change (1 year)
-44.89%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lukas Biomedical Inc. (6814)
Category
Healthcare
Operating Margin for Lukas Biomedical Inc. (6814)
Operating Margin as of November 2026 TTM: -51.26%
According to Lukas Biomedical Inc.'s latest financial reports, its current operating margin (TTM) is -51.26%. At the end of 2025 the company had an operating margin of -45.22%.
Operating Margin history for Lukas Biomedical Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -51.26% | 13.36% |
| 2025 | -45.22% | -6.84% |
| 2024 | -48.54% | 158.33% |
| 2023 | -18.79% | -28.36% |
| 2022 | -26.23% | -3.99% |
| 2021 | -27.32% | 665.27% |
| 2020 | -3.57% | -22.39% |
| 2019 | -4.60% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.75% |
US
|
|
| -149.01% | -97.09% |
US
|
|
| 25.57% | -100.50% |
AU
|
|
| 31.23% | -100.61% |
BE
|
|
| 29.35% | -100.57% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Lukas Biomedical Inc.'s operating margin
What is Lukas Biomedical Inc.'s operating margin?
Lukas Biomedical Inc.'s operating margin is -51.26%, as of Nov 2026.
What was Lukas Biomedical Inc.'s operating margin in 2025?
In 2025, Lukas Biomedical Inc.'s operating margin was -45.22%, compared with -48.54% in 2024.
How has Lukas Biomedical Inc.'s operating margin changed since 2020?
From 2020 to 2025, Lukas Biomedical Inc.'s operating margin was highest in 2020 (-3.57%) and lowest in 2024 (-48.54%).
How does Lukas Biomedical Inc.'s operating margin compare with similar companies?
Lukas Biomedical Inc.'s operating margin (-51.26%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.